--- title: "Hospital Corporation of China Limited (03869.HK)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/03869.HK.md" symbol: "03869.HK" name: "Hospital Corporation of China Limited" industry: "Health Care Services" --- # Hospital Corporation of China Limited (03869.HK) | Item | Detail | |------|--------| | Industry | Health Care Services | | Location | HK Market | | Website | [www.hcclhealthcare.com](https://www.hcclhealthcare.com) | ## Company Profile Hospital Corporation of China Limited, an investment holding company, owns, operates, and manages hospitals in the People’s Republic of China. The company operates through three segments: General Hospital Services; Hospital Management Services; and Sale of Pharmaceutical Products. The company provid... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-18T04:30:11.000Z **Overall: C (0.44)** **Industry**: Health Care Services | Metric | Value | |--------|-------| | Industry Ranking | 11 / 29 | | Industry Median | C | | Industry Average | C | - **Style**: Blend - Stocks in which the company has both growth and mature businesses. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 2.70% | | | Net Profit YoY | 978.12% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 1.27 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 710.24M | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 1.59B | | **Multi Score**: C #### Profit Score: B | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 31.25% | A | | Profit Margin | 9.26% | B | | Gross Margin | 19.79% | D | #### Growth Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 2.70% | C | | Net Profit YoY | 978.12% | A | | Total Assets YoY | 4.03% | C | | Net Assets YoY | 20.96% | A | #### Cash Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | 1079.91% | B | | OCF YoY | 2.70% | C | #### Operating Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.58 | B | #### Debt Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 71.44% | D | ```chart-data:radar { "title": "Longbridge Financial Score - Hospital Corporation of China Limited", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "B", "indicators": [ { "name": "ROE", "value": "31.25%", "rating": "A" }, { "name": "Profit Margin", "value": "9.26%", "rating": "B" }, { "name": "Gross Margin", "value": "19.79%", "rating": "D" } ] }, { "name": "Growth", "grade": "B", "indicators": [ { "name": "Revenue YoY", "value": "2.70%", "rating": "C" }, { "name": "Net Profit YoY", "value": "978.12%", "rating": "A" }, { "name": "Total Assets YoY", "value": "4.03%", "rating": "C" }, { "name": "Net Assets YoY", "value": "20.96%", "rating": "A" } ] }, { "name": "Cash", "grade": "C", "indicators": [ { "name": "Cash Flow Margin", "value": "1079.91%", "rating": "B" }, { "name": "OCF YoY", "value": "2.70%", "rating": "C" } ] }, { "name": "Operating", "grade": "B", "indicators": [ { "name": "Turnover", "value": "0.58", "rating": "B" } ] }, { "name": "Security", "grade": "D", "indicators": [ { "name": "Gearing Ratio", "value": "71.44%", "rating": "D" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | GUSHENGTANG (HK.2273) | B | B | B | B | B | B | | 02 | HUMAN HEALTH (HK.1419) | C | C | B | B | B | B | | 03 | UNI MEDICAL (HK.2666) | B | C | D | D | B | C | | 04 | HEALTHYWAY INC (HK.2587) | B | C | A | D | E | C | | 05 | DISTINCT HEALTH (HK.2677) | D | A | B | E | B | C | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | 4.77 | 3/29 | 6.29 | 5.57 | 5.29 | | PB | 1.27 | 14/29 | 2.46 | 1.70 | 1.48 | | PS (TTM) | 0.44 | 2/29 | 0.60 | 0.52 | 0.46 | | Dividend Yield | 0.00% | - | - | - | - | ## References - [Company Overview](https://longbridge.com/en/quote/03869.HK/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/03869.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/03869.HK/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.